Evidence map›Paper›PMID 41784877›Full record

ArticleJournal of neuro-oncology2026

Adolescents and young adults with predominantly low grade primary central nervous system tumors: patient reported socioeconomic outcomes and health-related quality of life ten years after diagnosis.

Thomas Mayen, Magali Morelle, Sonia Zouaoui, Mazen Kallel, Jean Michel Lemée, Audrey Saadoun, Hélène Cebula, Sandra Aouaissia, Abdullah Al Awadhi, Arthur Leclerc and 8 more

Abstract read
In one paragraph

Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Thomas MayenUniversity Claude Bernard Lyon 1, Lyon, F-69008, France.
Magali MorelleCentre Léon Bérard, CNRS, Université Lumière Lyon 2, Université Jean Monnet Saint-Etienne, Emlyon Business School, GATE, Lyon, France.
Sonia ZouaouiDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
Mazen KallelDepartment of Neurosurgery, University Grenoble Alpes, Grenoble, France.
Jean Michel LeméeDepartment of Neurosurgery, CHU Angers, Angers, 49933, France.
Audrey SaadounDepartment of Neurosurgery, University Hospital of Dijon Bourgogne, Dijon, France.
Hélène CebulaDepartment of Neurosurgery, University Hospital of Strasbourg, Strasbourg, F-67000, France.
Sandra AouaissiaDepartment of Neurosurgery, Rennes University Hospital, Rennes, France.
Abdullah Al AwadhiDepartment of Neurosurgery, Rothschild Foundation Hospital, Paris, France.
Arthur LeclercDepartment of Neurosurgery, University Hospital of Caen, Caen, F-14000, France.
Anne HerbrechtDepartment of Neurosurgery, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, France.
Julien BoettoDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
Amélie DarlixMedical Oncology Department, Institut du Cancer de Montpellier, Institut de Génomique Fonctionnelle, INSERM, CNRS, University of Montpellier, Montpellier, France.
Valérie RigauFrench Brain Tumor DataBase, GNOLR, CHU/ICM Montpellier, Montpellier, France.
Brigitte TrétarreRegistre des Tumeurs de l'Hérault, Institut du Cancer de Montpellier, Montpellier, France.
Thomas RoujeauDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
Luc BauchetDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.
Nora MoumjidUniversity Claude Bernard Lyon 1, Lyon, F-69008, France. nora.moumjid@univ-lyon1.fr.

Funding

Ligue Contre le Cancer N°PREAC2017.LCC/TR
6 · The paper itself

Abstract

contextAdolescents and young adults (AYAs) diagnosed with primary central nervous system tumors (PCNST) often face long-term socio-economic challenges and reduced health-related quality of life (HRQoL).

objectiveThis study aims to evaluate the long-term socio-economic outcomes and HRQoL of AYAs more than ten years after diagnosis.

methodsA national, retrospective study conducted between 2019 and 2022, including AYAs aged 15–25 diagnosed with PCNST in 2009–2010, identified through the French Brain Tumor Database. Socio-economic data and HRQoL were assessed using a structured questionnaire and the Short Form-12 (SF-12) Health Survey. Descriptive statistical analyses were performed.

resultsQuestionnaires were available for 70 patients. Educational level improved over time, but 11.4% still lacked a diploma. While 90% were employed, 45% earned €1500–€2500 per month, and 36.7% earned less than €1500 per month. Workplace accommodations were rarely implemented despite needs. HRQoL assessments showed high physical functioning scores (mean: 85.61), but low vitality scores (mean: 35.82). The mean Physical Component Summary and the mean Mental Component Summary are lower to the general population aged 18–44 in France, respectively 50.6 (SD: 9.1) and 43.6 (SD:12.25) showing a poor physical and a very poor mental HRQoL for AYAs survivors. DISCUSSION: Despite resilience in education and employment, AYAs surviving PCNST face persistent socio-economic difficulties and poor mental HRQoL. Tailored interventions, including increased awareness of support resources and comprehensive care strategies, are needed to improve their long-term outcomes and facilitate better integration into society. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Central Nervous System NeoplasmsQuality of LifeAdolescentAdultFemaleFollow-Up StudiesHumansMalePatient Reported Outcome MeasuresRetrospective StudiesSocioeconomic Disparities in HealthSocioeconomic FactorsSurveys and QuestionnairesYoung AdultAdolescents and young adults (AYAs)Brain tumorHealth-related quality of life (HRQoL)Socioeconomic outcomes

Identifiers

PMID41784877
PMCPMC12963085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.